Brind.

NeOnc Technologies Holdings is seeking FDA development pathways for its products, utilizing the Fast Track designation, and is listed on Nasdaq.

2 reports, 2 independent Updated Aug 11

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 3
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

NeOnc Technologies Holdings is seeking FDA development pathways for its products, utilizing the Fast Track designation, and is listed on Nasdaq.

Who's involved

What this event is mainly about

FDA Nasdaq Fast Track

How it developed

Newest first. Tap a step to see who reported it.

Aug 18NeOnc Technologies was listed on Nasdaq and filed a purchase disclosure with the SEC.Sub-event
Aug 12Market attention is focused on NeOnc Technologies Holdings due to positive clinical trial results and discussions regarding the path toward a registrational study.Sub-event
Aug 10NeOnc is seeking FDA development pathways and utilizing Fast Track designation.1 source
- manilatimes.net

Keep exploring

The entities involved

FDA
- Neurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.13:51
- Clene Inc. submitted an NDA to the FDA seeking accelerated approval while trading on the Nasdaq exchange.11:34
Nasdaq
American fully electronic stock exchange
- A Vertex employee won an Info-Tech award, the company is listed on Nasdaq, and Sarah Vlasic leads Leadership Circles at the University of Colorado Boulder.14:50
- NYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.14:38
Fast Track
American company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 11finanznachrichten.de
Aug 10manilatimes.net